Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer
- Tolaney, S.M.
- Guarneri, V.
- Seo, J.H.
- Cruz, J.
- Abreu, M.H.
- Takahashi, M.
- Barrios, C.
- McIntyre, K.
- Wei, R.
- Munoz, M.
- Antonio, B.S.
- Liepa, A.M.
- Martin, M.
- Johnston, S.R.D.
- Kellokumpu-Lehtinen, P.-L.
- Harbeck, N.
Journal:
European Journal of Cancer
ISSN: 1879-0852, 0959-8049
Year of publication: 2024
Volume: 199
Type: Article